BioNTech Aktie 50030055 / US09075V1026
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
07.05.2026 13:00:02
|
BioNTech Board Authorizes $1 Bln ADS Repurchase Program
(RTTNews) - Thursday, BioNTech SE (BNTX) announced that its board has authorized a new program to repurchase American Depositary Shares or ADS for an aggregate amount of up to $1.0 billion.
The company intends to use the repurchased ADSs to satisfy obligations in the ordinary course of business. Also, it believes that the program is consistent with the company's capital allocation strategy as well as its commitment to sustainable value creation for the shareholders.
Repurchases under the program may be made until and including May 6, 2027.
In the pre-market hours, BNTX is trading at $95.34, up 0.09 percent on the Nasdaq.
Trading Signals: Stadler Rail: Auf dem richtigen Gleis
Der Zughersteller ist dabei, zentrale Bremsklötze zu lösen. Mit einem optimistischen Ausblick hat Stadler Rail die Investoren dazu gebracht, wieder einzusteigen - jetzt nimmt der Mid Cap Fahrt auf.
Weiterlesen!